The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

(2015)   HEPATOLOGY

EASL Recommendations on Treatment of Hepatitis C 2015

(2015)   JOURNAL OF HEPATOLOGY

Hepatitis C: only a step away from elimination?

(2015) The Lancet   LANCET

Minimum Costs for Producing Hepatitis C Direct-Acting Antivirals for Use in Large-Scale Treatment Access Programs in Developing Countries

(2014) A. Hill et al.   CLINICAL INFECTIOUS DISEASES

O68 SOFOSBUVIR AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HCV WITH CIRRHOSIS AND PORTAL HYPERTENSION WITH AND WITHOUT DECOMPENSATION: EARLY VIROLOGIC RESPONSE AND SAFETY

(2014) N. Afdhal et al.   JOURNAL OF HEPATOLOGY

Hepatitis C and HIV Co-Infection: New Drugs in Practice and in the Pipeline

(2012) Carrie L. Jennings et al.   Current HIV/AIDS Reports

Evolving epidemiology of hepatitis C virus

(2010) D. Lavanchy   CLINICAL MICROBIOLOGY AND INFECTION